News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

QuantomiX Ltd Release: Lipid Imaging Tool For Drug Development In Metabolic Diseases To Be Presented At Bio-Tech Israel 2005


10/19/2005 5:10:00 PM

TEL AVIV, Israel--(BUSINESS WIRE)--May 18, 2005--QuantomiX Ltd. will present its high-resolution lipid imaging technology at Bio-Tech Israel 2005 on May 24, accompanied by high expectations from industry leaders. This technology permits high resolution imaging, analysis, and quantification of lipid bodies in cells and tissues (liver, muscle, adipose tissue etc.) - a capability that can serve as an early indication for the onset of metabolic disorders. Recent research has revealed that lipid imaging using QuantomiX WETSEM(TM) technology may hold the key to drug evaluation for metabolic diseases.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES